Phase II trial of Remitogen™ (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma

被引：27
作者：
Brown, KS
Levitt, DJ
Shannon, M
Link, BK
机构：
[1] Univ Iowa, Dept Internal Med, Div Hematol Oncol & Blood & Marrow Transplant, Iowa City, IA 52242 USA
[2] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[3] Prot Design Labs, Fremont, CA USA
来源：
CLINICAL LYMPHOMA | 2001年 / 2卷 / 03期
关键词：
D O I：
10.3816/CLM.2001.n.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：188 / 190
页数：3
相关论文
共 10 条
  • [1] ALTOMONTE M, 1993, J IMMUNOL, V151, P5115
  • [2] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    Cheson, BD
    Horning, SJ
    Coiffier, B
    Shipp, MA
    Fisher, RI
    Connors, JM
    Lister, TA
    Vose, J
    Grillo-López, A
    Hagenbeek, A
    Cabanillas, F
    Klippensten, D
    Hiddemann, W
    Castellino, R
    Harris, NL
    Armitage, JO
    Carter, W
    Hoppe, R
    Canellos, GP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1244 - 1253
  • [3] Coiffier B, 1998, BLOOD, V92, P1927
  • [4] Coiffier B, 2000, BLOOD, V96, p223A
  • [5] GINGRICH RD, 1990, BLOOD, V75, P2375
  • [6] Green JM, 2000, BLOOD, V96, p133A
  • [7] GROWTH-INHIBITION OF EPSTEIN-BARR VIRUS-TRANSFORMED B-CELLS BY ANTI-HLA-DR ANTIBODY L243 - POSSIBLE RELATIONSHIP TO L243-INDUCED DOWN-REGULATION OF CD23 ANTIGEN EXPRESSION
    KABELITZ, D
    JANSSEN, O
    [J]. CELLULAR IMMUNOLOGY, 1989, 120 (01) : 21 - 30
  • [8] Humanization and characterization of the anti-HLA-DR antibody 1D10
    Kostelny, SA
    Link, BK
    Tso, JY
    Vasquez, M
    Jorgensen, BH
    Wang, H
    Hall, WC
    Weiner, GJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) : 556 - 565
  • [9] Link BK, 2000, P AM SOC CLIN ONCOL, V19, p24a
  • [10] Maloney DG, 1997, BLOOD, V90, P2188
1